Denial Of Dismissal Bid In Pharmaceutical Company's Stock-Drop Suit Upheld

Mealey's (July 31, 2020, 8:09 AM EDT) -- NEW YORK — A biopharmaceutical company and three of its senior officers have failed to sufficiently show that a federal judge in New York erred in denying their motion to dismiss...
To view the full article, register now.